IBDEI02Q ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3269,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,3269,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,3269,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,3270,0)
 ;;=285.21^^26^285^8
 ;;^UTILITY(U,$J,358.3,3270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3270,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,3270,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,3270,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,3271,0)
 ;;=285.29^^26^285^10
 ;;^UTILITY(U,$J,358.3,3271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3271,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,3271,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,3271,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,3272,0)
 ;;=284.9^^26^285^11
 ;;^UTILITY(U,$J,358.3,3272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3272,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,3272,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,3272,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,3273,0)
 ;;=282.61^^26^285^71
 ;;^UTILITY(U,$J,358.3,3273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3273,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,3273,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,3273,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,3274,0)
 ;;=282.7^^26^285^70
 ;;^UTILITY(U,$J,358.3,3274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3274,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,3274,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,3274,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,3275,0)
 ;;=283.9^^26^285^73
 ;;^UTILITY(U,$J,358.3,3275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3275,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,3275,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,3275,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,3276,0)
 ;;=283.0^^26^285^74
 ;;^UTILITY(U,$J,358.3,3276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3276,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,3276,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,3276,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,3277,0)
 ;;=282.9^^26^285^72
 ;;^UTILITY(U,$J,358.3,3277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3277,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,3277,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,3277,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,3278,0)
 ;;=283.19^^26^285^75
 ;;^UTILITY(U,$J,358.3,3278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3278,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,3278,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,3278,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,3279,0)
 ;;=280.9^^26^285^79
 ;;^UTILITY(U,$J,358.3,3279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3279,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,3279,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,3279,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,3280,0)
 ;;=285.1^^26^285^77
 ;;^UTILITY(U,$J,358.3,3280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3280,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,3280,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,3280,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,3281,0)
 ;;=280.0^^26^285^78
 ;;^UTILITY(U,$J,358.3,3281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3281,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,3281,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,3281,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,3282,0)
 ;;=281.9^^26^285^99
 ;;^UTILITY(U,$J,358.3,3282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3282,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,3282,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,3282,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,3283,0)
 ;;=281.0^^26^285^119
 ;;^UTILITY(U,$J,358.3,3283,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3283,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,3283,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,3283,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,3284,0)
 ;;=282.60^^26^285^106
 ;;^UTILITY(U,$J,358.3,3284,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3284,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,3284,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,3284,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,3285,0)
 ;;=282.62^^26^285^107
 ;;^UTILITY(U,$J,358.3,3285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3285,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,3285,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,3285,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,3286,0)
 ;;=281.1^^26^285^120
 ;;^UTILITY(U,$J,358.3,3286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3286,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,3286,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,3286,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,3287,0)
 ;;=286.7^^26^285^47
 ;;^UTILITY(U,$J,358.3,3287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3287,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,3287,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,3287,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,3288,0)
 ;;=289.9^^26^285^115
 ;;^UTILITY(U,$J,358.3,3288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3288,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,3288,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,3288,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,3289,0)
 ;;=451.9^^26^285^116
 ;;^UTILITY(U,$J,358.3,3289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3289,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,3289,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,3289,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,3290,0)
 ;;=446.6^^26^285^117
 ;;^UTILITY(U,$J,358.3,3290,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3290,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,3290,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,3290,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,3291,0)
 ;;=286.4^^26^285^121
 ;;^UTILITY(U,$J,358.3,3291,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3291,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,3291,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,3291,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,3292,0)
 ;;=204.00^^26^285^4
 ;;^UTILITY(U,$J,358.3,3292,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3292,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,3292,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,3292,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,3293,0)
 ;;=204.01^^26^285^3
 ;;^UTILITY(U,$J,358.3,3293,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3293,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,3293,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,3293,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,3294,0)
 ;;=204.10^^26^285^43
 ;;^UTILITY(U,$J,358.3,3294,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3294,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,3294,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,3294,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,3295,0)
 ;;=204.11^^26^285^42
 ;;^UTILITY(U,$J,358.3,3295,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3295,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,3295,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,3295,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,3296,0)
 ;;=201.90^^26^285^76
 ;;^UTILITY(U,$J,358.3,3296,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3296,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,3296,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,3296,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,3297,0)
 ;;=785.6^^26^285^83
 ;;^UTILITY(U,$J,358.3,3297,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3297,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,3297,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,3297,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,3298,0)
 ;;=200.20^^26^285^85
 ;;^UTILITY(U,$J,358.3,3298,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3298,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,3298,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,3298,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,3299,0)
 ;;=202.00^^26^285^87
 ;;^UTILITY(U,$J,358.3,3299,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3299,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,3299,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,3299,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,3300,0)
 ;;=200.10^^26^285^86
 ;;^UTILITY(U,$J,358.3,3300,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3300,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,3300,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,3300,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,3301,0)
 ;;=273.3^^26^285^88
 ;;^UTILITY(U,$J,358.3,3301,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3301,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,3301,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,3301,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,3302,0)
 ;;=203.00^^26^285^97
 ;;^UTILITY(U,$J,358.3,3302,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3302,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,3302,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,3302,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,3303,0)
 ;;=203.01^^26^285^96
 ;;^UTILITY(U,$J,358.3,3303,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3303,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,3303,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,3303,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,3304,0)
 ;;=238.6^^26^285^100
 ;;^UTILITY(U,$J,358.3,3304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3304,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,3304,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,3304,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,3305,0)
 ;;=205.00^^26^285^6
 ;;^UTILITY(U,$J,358.3,3305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3305,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,3305,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,3305,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,3306,0)
 ;;=205.01^^26^285^5
 ;;^UTILITY(U,$J,358.3,3306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3306,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,3306,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,3306,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,3307,0)
 ;;=205.10^^26^285^45
